LINC01224/ZNF91 Promote Stem Cell-Like Properties and Drive Radioresistance in Non-Small Cell Lung Cancer

References

• Chen W, Zheng R, Baade PD, et al. Cancer statistics in China, 2015. CA Cancer J Clin. 2016;66(2):115–132. doi:10.3322/caac.2133826808342
   PubMed Web of Science ®Google Scholar
• Siegel RL, Miller KD, Jemal A. Cancer statistics, 2020. CA Cancer J Clin. 2020;70(1):7–30. doi:10.3322/caac.2159031912902
   PubMed Web of Science ®Google Scholar
• Thomas A, Liu SV, Subramaniam DS, Giaccone G. Refining the treatment of NSCLC according to histological and molecular subtypes. Nat Rev Clin Oncol. 2015;12(9):511–526. doi:10.1038/nrclinonc.2015.9025963091
   PubMed Web of Science ®Google Scholar
• Herbst RS, Morgensztern D, Boshoff C. The biology and management of non-small cell lung cancer. Nature. 2018;553(7689):446–454. doi:10.1038/nature2518329364287
   PubMed Web of Science ®Google Scholar
• Rotow J, Bivona TG. Understanding and targeting resistance mechanisms in NSCLC. Nat Rev Cancer. 2017;17:637–658.29068003
   PubMed Web of Science ®Google Scholar
• Uszczynska-Ratajczak B, Lagarde J, Frankish A, Guigó R, Johnson R. Towards a complete map of the human long non-coding RNA transcriptome. Nat Rev Genet. 2018;19(9):535–548. doi:10.1038/s41576-018-0017-y29795125
   PubMed Web of Science ®Google Scholar
• Quinn JJ, Chang HY. Unique features of long non-coding RNA biogenesis and function. Nat Rev Genet. 2016;17(1):47–62. doi:10.1038/nrg.2015.1026666209
   PubMed Web of Science ®Google Scholar
• Ransohoff JD, Wei Y, Khavari PA. The functions and unique features of long intergenic non-coding RNA. Nat Rev Mol Cell Biol. 2018;19(3):143–157. doi:10.1038/nrm.2017.10429138516
   PubMed Web of Science ®Google Scholar
• Yao R-W, Wang Y, Chen -L-L. Cellular functions of long noncoding RNAs. Nat Cell Biol. 2019;21(5):542–551. doi:10.1038/s41556-019-0311-831048766
   PubMed Web of Science ®Google Scholar
• Romero-Barrios N, Legascue MF, Benhamed M, Ariel F, Crespi M. Splicing regulation by long noncoding RNAs. Nucleic Acids Res. 2018;46(5):2169–2184. doi:10.1093/nar/gky09529425321
   PubMed Web of Science ®Google Scholar
• Anastasiadou E, Jacob LS, Slack FJ. Non-coding RNA networks in cancer. Nat Rev Cancer. 2018;18(1):5–18. doi:10.1038/nrc.2017.9929170536
   PubMed Web of Science ®Google Scholar
• Calle AS, Kawamura Y, Yamamoto Y, Takeshita F, Ochiya T. Emerging roles of long non-coding RNA in cancer. Cancer Sci. 2018;109:2093–2100. doi:10.1111/cas.1364229774630
   PubMed Web of Science ®Google Scholar
• Bhan A, Soleimani M, Mandal SS. Long noncoding RNA and cancer: a new paradigm. Cancer Res. 2017;77:3965–3981. doi:10.1158/0008-5472.CAN-16-263428701486
   PubMed Web of Science ®Google Scholar
• Huang S, Zhan Z, Li L, et al. LINC00958-MYC positive feedback loop modulates resistance of head and neck squamous cell carcinoma cells to chemo- and radiotherapy in vitro. Oncotarget Ther. 2019;12:5989–6000. doi:10.2147/OTT.S208318
   PubMed Web of Science ®Google Scholar
• Huo X, Han S, Wu G, et al. Dysregulated long noncoding RNAs (lncRNAs) in hepatocellular carcinoma: implications for tumorigenesis, disease progression, and liver cancer stem cells. Mol Cancer. 2017;16(1):165. doi:10.1186/s12943-017-0734-429061150
   PubMed Web of Science ®Google Scholar
• Chi HC, Tsai CY, Tsai MM, Yeh CT, Lin KH. Roles of long noncoding RNAs in recurrence and metastasis of radiotherapy-resistant cancer stem cells. Int J Mol Sci. 2017;18:1903. doi:10.3390/ijms18091903
   PubMed Web of Science ®Google Scholar
• Yan L, Xu G, Qiao T, et al. CpG-ODN 7909 increases radiation sensitivity of radiation-resistant human lung adenocarcinoma cell line by overexpression of toll-like receptor 9. Cancer Biother Radiopharm. 2013;28(7):559–564. doi:10.1089/cbr.2012.145023705865
   PubMed Web of Science ®Google Scholar
• Hagège H, Klous P, Braem C, et al. Quantitative analysis of chromosome conformation capture assays (3C-qPCR). Nat Protoc. 2007;2(7):1722–1733. doi:10.1038/nprot.2007.24317641637
   PubMed Web of Science ®Google Scholar
• Li W, Notani D, Rosenfeld MG. Enhancers as non-coding RNA transcription units: recent insights and future perspectives. Nat Rev Genet. 2016;17(4):207–223. doi:10.1038/nrg.2016.426948815
   PubMed Web of Science ®Google Scholar
• Baker S, Dahele M, Lagerwaard FJ, Senan S. A critical review of recent developments in radiotherapy for non-small cell lung cancer. Radiat Oncol. 2016;11(1):115. doi:10.1186/s13014-016-0693-827600665
   PubMed Web of Science ®Google Scholar
• Li L, Zhu T, Gao Y-F, et al. Targeting DNA damage response in the radio(chemo)therapy of non-small cell lung cancer. Int J Mol Sci. 2016;17(6):839. doi:10.3390/ijms17060839
   PubMed Web of Science ®Google Scholar
• Yu Z, Wang G, Zhang C, et al. LncRNA SBF2-AS1 affects the radiosensitivity of non-small cell lung cancer via modulating microRNA-302a/MBNL3 axis. Cell Cycle. 2020;19(3):300–316. doi:10.1080/15384101.2019.170801631928130
   PubMed Web of Science ®Google Scholar
• Xing S, Zhang Y, Zhang J. LINC01224 exhibits cancer-promoting activity in epithelial ovarian cancer through micro RNA-485-5p-mediated PAK4 upregulation. Oncotarget Ther. 2020;13:5643–5655. doi:10.2147/OTT.S254662
   PubMed Web of Science ®Google Scholar
• Li H, Gao C, Liu L, et al. 7-lncRNA assessment model for monitoring and prognosis of breast cancer patients: based on cox regression and co-expression analysis. Front Oncol. 2019;9:1348. doi:10.3389/fonc.2019.0134831850229
   PubMed Web of Science ®Google Scholar
• Gong D, Feng PC, Ke XF, et al. Silencing long non-coding RNA LINC01224 inhibits hepatocelular carcinoma progression via microRNA-330-5p-induced inhibition of CHEK1. Mol Ther Nucleic Acids. 2020;19:482–497. doi:10.1016/j.omtn.2019.10.00731902747
   PubMedGoogle Scholar
• Rothschild G, Basu U. Lingering questions about enhancer RNA and enhancer transcription-coupled genomic instability. Trends Genet. 2017;33:143–154. doi:10.1016/j.tig.2016.12.00228087167
   PubMed Web of Science ®Google Scholar
• Lewis MW, Li S, Franco HL. Transcriptional control by enhancers and enhancer RNAs. Transcription. 2019;10(4–5):171–186. doi:10.1080/21541264.2019.169549231791217
   PubMedGoogle Scholar
• Ntini E, Marsico A. Functional impacts of non-coding RNA processing on enhancer activity and target gene expression. J Mol Cell Biol. 2019;11:868–879. doi:10.1093/jmcb/mjz04731169884
   PubMed Web of Science ®Google Scholar
• Mao R, Wu Y, Ming Y, et al. Enhancer RNAs: a missing regulatory layer in gene transcription. Sci China Life Sci. 2019;62(7):905–912. doi:10.1007/s11427-017-9370-930593613
   PubMed Web of Science ®Google Scholar
• Lam MT, Li W, Rosenfeld MG, Glass CK. Enhancer RNAs and regulated transcriptional programs. Trends Biochem Sci. 2014;39:170–182. doi:10.1016/j.tibs.2014.02.00724674738
   PubMed Web of Science ®Google Scholar
• Rahnamoun H, Lee J, Sun Z, et al. RNAs interact with BRD4 to promote enhanced chromatin engagement and transcription activation. Nat Struct Mol Biol. 2018;25(8):687–697. doi:10.1038/s41594-018-0102-030076409
   PubMed Web of Science ®Google Scholar
• Pnueli L, Rudnizky S, Yosefzon Y, Melamed P. RNA transcribed from a distal enhancer is required for activating the chromatin at the promoter of the gonadotropin α-subunit gene. Proc Natl Acad Sci USA. 2015;112(14):4369–4374. doi:10.1073/pnas.141484111225810254
   PubMed Web of Science ®Google Scholar
• Meng H, Bartholomew B. Emerging roles of transcriptional enhancers in chromatin looping and promoter-proximal pausing of RNA polymerase II. J Biol Chem. 2018;293(36):13786–13794. doi:10.1074/jbc.R117.81348529187597
   PubMed Web of Science ®Google Scholar
• Unoki M, Okutsu J, Nakamura Y. Identification of a novel human gene, ZFP91, involved in acute myelogenous leukemia. Int J Oncol. 2003;22:1217–1223.12738986
   PubMed Web of Science ®Google Scholar
• Han Y, Zheng Q, Tian Y, Ji Z, Ye H. Identification of a nine-gene panel as a prognostic indicator for recurrence with muscle-invasive bladder cancer. J Surg Oncol. 2019;119(8):1145–1154. doi:10.1002/jso.2544630887516
   PubMed Web of Science ®Google Scholar
• Dufresne J, Bowden P, Thavarajah T, et al. The plasma peptides of ovarian cancer. Clin Proteomics. 2018;15(1):41. doi:10.1186/s12014-018-9215-z30598658
   PubMed Web of Science ®Google Scholar
• Lytle NK, Barber AG, Reya T. Stem cell fate in cancer growth, progression and therapy resistance. Nat Rev Cancer. 2018;18(11):669–680. doi:10.1038/s41568-018-0056-x30228301
   PubMed Web of Science ®Google Scholar
• Carnero A, Garcia-Mayea Y, Mir C, Lorente J, Rubio IT, LLeonart ME. The cancer stem-cell signaling network and resistance to therapy. Cancer Treat Rev. 2016;49:25–36. doi:10.1016/j.ctrv.2016.07.00127434881
   PubMed Web of Science ®Google Scholar
• MacDonagh L, Gray SG, Breen E, et al. Lung cancer stem cells: the root of resistance. Cancer Lett. 2016;372(2):147–156. doi:10.1016/j.canlet.2016.01.01226797015
   PubMed Web of Science ®Google Scholar